These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23802813)

  • 21. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.
    Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM
    Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
    Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
    Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergence of bacterial communities in the lower airways of CF patients in early childhood.
    O'Connor JB; Mottlowitz MM; Wagner BD; Boyne KL; Stevens MJ; Robertson CE; Harris JK; Laguna TA
    PLoS One; 2021; 16(10):e0257838. PubMed ID: 34613995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function.
    Paganin P; Fiscarelli EV; Tuccio V; Chiancianesi M; Bacci G; Morelli P; Dolce D; Dalmastri C; De Alessandri A; Lucidi V; Taccetti G; Mengoni A; Bevivino A
    PLoS One; 2015; 10(4):e0124348. PubMed ID: 25898134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.
    Hogan DA; Willger SD; Dolben EL; Hampton TH; Stanton BA; Morrison HG; Sogin ML; Czum J; Ashare A
    PLoS One; 2016; 11(3):e0149998. PubMed ID: 26943329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trials.
    Weiser R; Rye PD; Mahenthiralingam E
    J Microbiol Methods; 2021 Feb; 181():106133. PubMed ID: 33421446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia.
    Ratjen F; Waters V; Klingel M; McDonald N; Dell S; Leahy TR; Yau Y; Grasemann H
    Eur Respir J; 2016 Mar; 47(3):829-36. PubMed ID: 26585432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlamydia pneumoniae and Mycoplasma pneumoniae in children with cystic fibrosis: impact on bacterial respiratory microbiota diversity.
    Pittet LF; Bertelli C; Scherz V; Rochat I; Mardegan C; Brouillet R; Jaton K; Mornand A; Kaiser L; Posfay-Barbe K; Asner SA; Greub G
    Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33247928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation.
    Twomey KB; Alston M; An SQ; O'Connell OJ; McCarthy Y; Swarbreck D; Febrer M; Dow JM; Plant BJ; Ryan RP
    PLoS One; 2013; 8(12):e82432. PubMed ID: 24358183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis.
    Soret P; Vandenborght LE; Francis F; Coron N; Enaud R; Avalos M; Schaeverbeke T; Berger P; Fayon M; Thiebaut R; Delhaes L;
    Sci Rep; 2020 Feb; 10(1):3589. PubMed ID: 32108159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function.
    Bozzella MJ; Chaney H; Sami I; Koumbourlis A; Bost JE; Zemanick ET; Freishtat RJ; Crandall KA; Hahn A
    Pediatr Infect Dis J; 2021 Nov; 40(11):962-968. PubMed ID: 34269323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation.
    Quinn RA; Whiteson K; Lim YW; Salamon P; Bailey B; Mienardi S; Sanchez SE; Blake D; Conrad D; Rohwer F
    ISME J; 2015 Mar; 9(4):1024-38. PubMed ID: 25514533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
    Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
    Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis.
    Frey DL; Boutin S; Dittrich SA; Graeber SY; Stahl M; Wege S; Herth FJF; Sommerburg O; Schultz C; Mall MA; Dalpke AH
    J Cyst Fibros; 2021 Sep; 20(5):754-760. PubMed ID: 33431308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation.
    Bernarde C; Keravec M; Mounier J; Gouriou S; Rault G; Férec C; Barbier G; Héry-Arnaud G
    PLoS One; 2015; 10(4):e0124124. PubMed ID: 25853698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations.
    Chin M; De Zoysa M; Slinger R; Gaudet E; Vandemheen KL; Chan F; Hyde L; Mah TF; Ferris W; Mallick R; Aaron SD
    J Cyst Fibros; 2015 Jul; 14(4):482-9. PubMed ID: 25544473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.
    Tunney MM; Einarsson GG; Wei L; Drain M; Klem ER; Cardwell C; Ennis M; Boucher RC; Wolfgang MC; Elborn JS
    Am J Respir Crit Care Med; 2013 May; 187(10):1118-26. PubMed ID: 23348972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.